NEW YORK, Aug. 7 – Gene Logic spinoff Metrigenix announced on Tuesday its first deal, saying it would work with Neuralstem to co-develop low-density oligonucleotide microarrays designed to study gene expression in the central nervous system.

Metrigenix will provide its Flow-thru Chip technology, while privately held Neuralstem, a developer of stem-cell technology for the human central nervous system, will contribute the content.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.